查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多株抗體抗體市場規模 - 按產品（一抗、二抗）、應用、給藥途徑（IV、SC）、來源（兔、山羊、小鼠、人類）、最終用戶、全球預測（2023-2032）
市場調查報告書
商品編碼
1399635

多株抗體抗體市場規模 - 按產品（一抗、二抗）、應用、給藥途徑（IV、SC）、來源（兔、山羊、小鼠、人類）、最終用戶、全球預測（2023-2032）

Polyclonal Antibodies Market Size - By Product (Primary Antibodies, Secondary Antibodies), Application, Route of Administration (IV, SC), Source (Rabbit, Goat, Mouse, Human), End-user, Global Forecast (2023-2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

由於診斷、治療和實驗研究應用範圍不斷擴大，2023年至2032年全球多株抗體抗體市場規模將以5.9%的CAGR成長。隨著生命科學和生物技術研究的深入，對多功能抗體的需求不斷增加。在診斷中，多克隆抗體在準確檢測中發揮關鍵作用，而其治療應用則可解決各種醫療狀況。隨著這些領域的不斷進步和研究活動的增加，多克隆抗體產業將不斷擴大，滿足醫療保健和生物技術領域診斷和治療應用的多樣化需求。

各組織積極致力於開發用於生命科學和生物技術領域研究的多克隆抗體。透過滿足多樣化的研究需求和推進科學應用，這對促進多克隆抗體市場做出了重大貢獻。例如，2022 年，專門從事生物醫學和生命科學基本產品和服務的經銷商 Amerigo Scientific 推出了一種針對人類凝血因子 XIII 的新型多克隆抗體。此抗體專為研究目的而設計，可幫助生命科學研究人員檢測凝血因子 XIII。它明確不適用於人類、治療或診斷應用。

多克隆抗體產業根據應用、最終用戶和地區進行細分。

受合約研究組織 (CRO) 在外包研究服務中的關鍵作用（提供抗體開發專業知識）的推動，到 2032 年，合約研究組織 (CRO) 部門將獲得相當大的佔有率。隨著生物製藥開發中對客製化解決方案的需求不斷成長，CRO 成為重要的合作夥伴，提供專業服務。他們在生產高品質多克隆抗體方面的能力將使該細分市場成為關鍵驅動力，滿足製藥和生物技術行業的特定需求，並在推進科學研究方面發揮至關重要的作用。

到 2032 年，研究應用領域將佔據相當大的佔有率，因為這些抗體在不同的研究應用中發揮著不可或缺的作用，特別是在生命科學和生物技術領域。它們在實驗、診斷和治療研究中的廣泛應用凸顯了它們的重要性。隨著人們越來越重視促進科學理解，研究應用領域將成為塑造多株抗體市場的基石，滿足各學科研究界不斷變化的需求。

在該地區強勁的生物製藥產業和大量研發投資的推動下，歐洲多株抗體市場將於 2023 年至 2032 年實現顯著的CAGR。歐洲市場受益於成熟的醫療基礎設施和豐富的科學景觀，促進了多克隆抗體應用的進步。慢性病的流行和對標靶治療的需求不斷增加，促進了該地區的突出地位，使歐洲成為塑造多克隆抗體行業前景的重要力量。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：多株抗體抗體市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 慢性病和傳染病的盛行率不斷上升
      • 對個人化藥物的需求不斷成長
      • 增加生物製藥研發活動
    • 產業陷阱與挑戰
      • 監理程序的嚴格性
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析
  • 管道分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：多株抗體抗體市場估計與預測：按產品，2018-2032

  • 主要動向：按產品
  • 一抗
  • 二抗

第 6 章：多株抗體抗體市場估計和預測：按應用，2018-2032

  • 主要動向：按應用
  • 診斷
  • 療法
  • 研究

第 7 章：多株抗體抗體市場估計與預測：按給藥途徑，2018-2032 年

  • 主要動向：按給藥途徑
  • 靜脈注射 (IV)
  • 皮下注射（SC）
  • 其他給藥途徑

第 8 章：多株抗體抗體市場估計與預測：按來源分類，2018-2032 年

  • 主要動向：依來源
  • 兔子
  • 山羊
  • 老鼠
  • 人類
  • 其他來源

第 9 章：多株抗體抗體市場估計與預測：按最終用戶，2018-2032 年

  • 主要動向：由最終用戶
  • 製藥和生物技術公司
  • 學術及研究機構
  • 合約研究組織 (CRO)
  • 診斷實驗室
  • 其他最終用戶

第 10 章：多株抗體抗體市場估計和預測：按地區，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 11 章：公司簡介

  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck Group (Merck KGaA)
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Cell Signaling Technology, Inc.
  • Rockland Immunochemicals Inc.
  • BioLegend, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Antibodies Inc.
  • Emergent
Product Code: 7456

Global Polyclonal Antibodies Market size will grow at a 5.9% CAGR from 2023 to 2032 due to expanding application scope in diagnostics, therapeutics, and experimental research. As life sciences and biotechnology research intensifies, there is a heightened demand for versatile antibodies. In diagnostics, polyclonal antibodies play a pivotal role in accurate detection, while their therapeutic applications address various medical conditions. With ongoing advancements and increased research activities in these domains, the polyclonal antibodies industry will expand, meeting the diverse needs of diagnostic and therapeutic applications within the healthcare and biotechnology sectors.

Organizations are actively engaged in developing polyclonal antibodies for research in the life sciences and biotechnology sectors. This contributes significantly to bolstering the polyclonal antibodies market by meeting diverse research needs and advancing scientific applications. For instance, in 2022, Amerigo Scientific, a distributor specializing in essential products and services for the biomedical and life sciences, unveiled a new polyclonal antibody targeting human blood coagulation factor XIII. Designed exclusively for research purposes, this antibody aids life science researchers in detecting blood coagulation factor XIII. It is expressly not intended for human, therapeutic, or diagnostic applications.

The polyclonal antibodies industry is segmented based on application, end-user, and region.

The contract research organizations (CROs) segment will secure a significant share by 2032, driven by CROs' pivotal role in outsourced research services, offering expertise in antibody development. With a rising demand for tailored solutions in biopharmaceutical development, CROs serve as essential partners, providing specialized services. Their proficiency in generating high-quality polyclonal antibodies will position the segment as a key driver, addressing the specific needs of the pharmaceutical and biotechnology industries and playing a crucial role in advancing scientific research.

The research application segment will capture a substantial share through 2032, attributed to the integral role these antibodies play in diverse research applications, particularly in life sciences and biotechnology. Their widespread use in experiments, diagnostics, and therapeutic research underscores their significance. With an increasing emphasis on advancing scientific understanding, the research application segment will be a cornerstone in shaping the polyclonal antibodies market, meeting the evolving needs of the research community across various disciplines.

Europe polyclonal antibodies market will register a notable CAGR from 2023 to 2032, propelled by the region's robust biopharmaceutical industry and substantial investments in research and development. The European market benefits from a mature healthcare infrastructure and a rich scientific landscape, fostering advancements in polyclonal antibody applications. The prevalence of chronic diseases and increasing demand for targeted therapeutics contribute to the region's prominence, positioning Europe as a significant force in shaping the polyclonal antibodies industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast Calculation
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Polyclonal antibodies industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Product trends
    • 2.1.4 Application trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Source trends
    • 2.1.7 End-user trends

Chapter 3 Polyclonal Antibodies Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic and infectious diseases
      • 3.2.1.2 Growing demand for personalized medicines
      • 3.2.1.3 Increasing biopharmaceutical R&D activities
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringency of regulatory procedures
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By source
    • 3.3.5 By end-users
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Pipeline Analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Polyclonal Antibodies Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

  • 5.1 Key trends, by product
  • 5.2 Primary antibodies
  • 5.3 Secondary antibodies

Chapter 6 Polyclonal Antibodies Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Diagnostics
  • 6.3 Therapeutics
  • 6.4 Research

Chapter 7 Polyclonal Antibodies Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Intravenous (IV)
  • 7.3 Subcutaneous (SC)
  • 7.4 Other routes of administration

Chapter 8 Polyclonal Antibodies Market Estimates and Forecast, By Source, 2018-2032 (USD Million)

  • 8.1 Key trends, by source
  • 8.2 Rabbit
  • 8.3 Goat
  • 8.4 Mouse
  • 8.5 Human
  • 8.6 Other sources

Chapter 9 Polyclonal Antibodies Market Estimates and Forecast, By End-users, 2018-2032 (USD Million)

  • 9.1 Key trends, by end-user
  • 9.2 Pharmaceutical and Biotechnology Companies
  • 9.3 Academic and Research Institutes
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Diagnostic Laboratories
  • 9.6 Other end-users

Chapter 10 Polyclonal Antibodies Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 Thermo Fisher Scientific Inc.
  • 11.2 F. Hoffmann-La Roche Ltd.
  • 11.3 Merck Group (Merck KGaA)
  • 11.4 Abcam plc
  • 11.5 Bio-Rad Laboratories, Inc.
  • 11.6 GenScript Biotech Corporation
  • 11.7 Cell Signaling Technology, Inc.
  • 11.8 Rockland Immunochemicals Inc.
  • 11.9 BioLegend, Inc.
  • 11.10 Santa Cruz Biotechnology, Inc.
  • 11.11 Antibodies Inc.
  • 11.12 Emergent

Data Tables

  • TABLE 1 Market revenue, by product (2022)
  • TABLE 2 Market revenue, by application (2022)
  • TABLE 3 Market revenue, by route of administration (2022)
  • TABLE 4 Market revenue, by source (2022)
  • TABLE 5 Market revenue, by end-user (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global polyclonal antibodies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global polyclonal antibodies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 10 Global polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 11 Global polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 12 Global polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 13 Global polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 14 Global polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 15 Global polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 16 Global polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 17 Global polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 18 Global polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 19 Industry impact forces
  • TABLE 20 Primary antibodies market, 2018 - 2022 (USD Million)
  • TABLE 21 Primary antibodies market, 2023 - 2032 (USD Million)
  • TABLE 22 Secondary antibodies market, 2018 - 2022 (USD Million)
  • TABLE 23 Secondary antibodies market, 2023 - 2032 (USD Million)
  • TABLE 24 Diagnostics market, 2018 - 2022 (USD Million)
  • TABLE 25 Diagnostics market, 2023 - 2032 (USD Million)
  • TABLE 26 Therapeutics market, 2018 - 2022 (USD Million)
  • TABLE 27 Therapeutics market, 2023 - 2032 (USD Million)
  • TABLE 28 Research market, 2018 - 2022 (USD Million)
  • TABLE 29 Research market, 2023 - 2032 (USD Million)
  • TABLE 30 Intravenous (IV)market, 2018 - 2022 (USD Million)
  • TABLE 31 Intravenous (IV)market, 2023 - 2032 (USD Million
  • TABLE 32 Subcutaneous (SC)market, 2018 - 2022 (USD Million)
  • TABLE 33 Subcutaneous (SC)market, 2023 - 2032 (USD Million
  • TABLE 34 Other routes of administration market by end-user, 2018 - 2022 (USD Million)
  • TABLE 35 Other routes of administration market, 2023 - 2032 (USD Million)
  • TABLE 36 Rabbit market, 2018 - 2022 (USD Million)
  • TABLE 37 Rabbit market, 2023 - 2032 (USD Million)
  • TABLE 38 Goat market, 2018 - 2022 (USD Million)
  • TABLE 39 Goat market, 2023 - 2032 (USD Million)
  • TABLE 40 Mouse market, 2018 - 2022 (USD Million)
  • TABLE 41 Mouse market, 2023 - 2032 (USD Million)
  • TABLE 42 Human market, 2018 - 2022 (USD Million)
  • TABLE 43 Human market, 2023 - 2032 (USD Million)
  • TABLE 44 Other sources market, 2018 - 2022 (USD Million)
  • TABLE 45 Other sources market, 2023 - 2032 (USD Million)
  • TABLE 46 Pharmaceutical and biotechnology companies market, 2018 - 2022 (USD Million)
  • TABLE 47 Pharmaceutical and biotechnology companies market, 2023 - 2032 (USD Million)
  • TABLE 48 Academic and research institutes market, 2018 - 2022 (USD Million)
  • TABLE 49 Academic and research institutes market, 2023 - 2032 (USD Million)
  • TABLE 50 Contract research organizations (CROs) market, 2018 - 2022 (USD Million)
  • TABLE 51 Contract research organizations (CROs) market, 2023 - 2032 (USD Million)
  • TABLE 52 Diagnostic laboratories market, 2018 - 2022 (USD Million)
  • TABLE 53 Diagnostic laboratories market, 2023 - 2032 (USD Million)
  • TABLE 54 Other end-users market, 2018 - 2022 (USD Million)
  • TABLE 55 Other end-users market, 2023 - 2032 (USD Million)
  • TABLE 56 North America polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
  • TABLE 57 North America polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
  • TABLE 58 North America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 59 North America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 60 North America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 61 North America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 62 North America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 63 North America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 64 North America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 65 North America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 66 North America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 67 North America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 68 U.S. polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 69 U.S. polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 70 U.S. polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 71 U.S. polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 72 U.S. polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 73 U.S. polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 74 U.S. polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 75 U.S. polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 76 U.S. polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 77 U.S. polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 78 Canada polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 79 Canada polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 80 Canada polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 81 Canada polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 82 Canada polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 83 Canada polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 84 Canada polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 85 Canada polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 86 Canada polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 87 Canada polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 88 Europe polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
  • TABLE 89 Europe polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
  • TABLE 90 Europe polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 91 Europe polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 92 Europe polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 93 Europe polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 94 Europe polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 95 Europe polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 96 Europe polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 97 Europe polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 98 Europe polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 99 Europe polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 100 Germany polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 101 Germany polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 102 Germany polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 103 Germany polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 104 Germany polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 105 Germany polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 106 Germany polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 107 Germany polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 108 Germany polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 109 Germany polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 110 UK polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 111 UK polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 112 UK polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 113 UK polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 114 UK polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 115 UK polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 116 UK polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 117 UK polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 118 UK polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 119 UK polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 120 France polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 121 France polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 122 France polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 123 France polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 124 France polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 125 France polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 126 France polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 127 France polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 128 France polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 129 France polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 130 Spain polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 131 Spain polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 132 Spain polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 133 Spain polyclonal antibodies market size, by application, 2023 - 2032 (USD Million
  • TABLE 134 Spain polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 135 Spain polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 136 Spain polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 137 Spain polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 138 Spain polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 139 Spain polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 140 Italy polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 141 Italy polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 142 Italy polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 143 Italy polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 144 Italy polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 145 Italy polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 146 Italy polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 147 Italy polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 148 Italy polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 149 Italy polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 150 Rest of Europe polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 151 Rest of Europe polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 152 Rest of Europe polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 153 Rest of Europe polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 154 Rest of Europe polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 155 Rest of Europe polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 156 Rest of Europe polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 157 Rest of Europe polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 158 Rest of Europe polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 159 Rest of Europe polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 160 Asia Pacific polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
  • TABLE 161 Asia Pacific polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
  • TABLE 162 Asia Pacific polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 163 Asia Pacific polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 164 Asia Pacific polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 165 Asia Pacific polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 166 Asia Pacific polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 167 Asia Pacific polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 168 Asia Pacific polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 169 Asia Pacific polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 170 Asia Pacific polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 171 Asia Pacific polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 172 China polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 173 China polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 174 China polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 175 China polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 176 China polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 177 China polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 178 China polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 179 China polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 180 China polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 181 China polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 182 Japan polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 183 Japan polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 184 Japan polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 185 Japan polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 186 Japan polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 187 Japan polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 188 Japan polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 189 Japan polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 190 Japan polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 191 Japan polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 192 India polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 193 India polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 194 India polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 195 India polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 196 India polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 197 India polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 198 India polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 199 India polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 200 India polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 201 India polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 202 Australia polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 203 Australia polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 204 Australia polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 205 Australia polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 206 Australia polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 207 Australia polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 208 Australia polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 209 Australia polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 210 Australia polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 211 Australia polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 212 Rest of Asia Pacific polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 213 Rest of Asia Pacific polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 214 Rest of Asia Pacific polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 215 Rest of Asia Pacific polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 216 Rest of Asia Pacific polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 217 Rest of Asia Pacific polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 218 Rest of Asia Pacific polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 219 Rest of Asia Pacific polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 220 Rest of Asia Pacific polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 221 Rest of Asia Pacific polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 222 Latin America polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
  • TABLE 223 Latin America polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
  • TABLE 224 Latin America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 225 Latin America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 226 Latin America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 227 Latin America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 228 Latin America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 229 Latin America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 230 Latin America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 231 Latin America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 232 Latin America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 233 Latin America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 234 Brazil polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 235 Brazil polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 236 Brazil polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 237 Brazil polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 238 Brazil polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 239 Brazil polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 240 Brazil polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 241 Brazil polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 242 Brazil polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 243 Brazil polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 244 Mexico polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 245 Mexico polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 246 Mexico polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 247 Mexico polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 248 Mexico polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 249 Mexico polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 250 Mexico polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 251 Mexico polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 252 Mexico polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 253 Mexico polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 254 Rest of Latin America polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 255 Rest of Latin America polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 256 Rest of Latin America polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 257 Rest of Latin America polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 258 Rest of Latin America polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 259 Rest of Latin America polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 260 Rest of Latin America polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 261 Rest of Latin America polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 262 Rest of Latin America polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 263 Rest of Latin America polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 264 Middle East & Africa polyclonal antibodies market size, by country, 2018 - 2022 (USD Million)
  • TABLE 265 Middle East & Africa polyclonal antibodies market size, by country, 2023 - 2032 (USD Million)
  • TABLE 266 Middle East & Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 267 Middle East & Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 268 Middle East & Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 269 Middle East & Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 270 Middle East & Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 271 Middle East & Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 272 Middle East & Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 273 Middle East & Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 274 Middle East & Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 275 Middle East & Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 276 South Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 277 South Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 278 South Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 279 South Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 280 South Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 281 South Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 282 South Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 283 South Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 284 South Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 285 South Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 286 Saudi Arabia polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 287 Saudi Arabia polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 288 Saudi Arabia polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 289 Saudi Arabia polyclonal antibodies market size, by application, 2023 - 2032 (USD Million
  • TABLE 290 Saudi Arabia polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 291 Saudi Arabia polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 292 Saudi Arabia polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 293 Saudi Arabia polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 294 Saudi Arabia polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 295 Saudi Arabia polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 296 Rest of Middle East & Africa polyclonal antibodies market size, by product, 2018 - 2022 (USD Million)
  • TABLE 297 Rest of Middle East & Africa polyclonal antibodies market size, by product, 2023 - 2032 (USD Million)
  • TABLE 298 Rest of Middle East & Africa polyclonal antibodies market size, by application, 2023 - 2032 (USD Million)
  • TABLE 299 Rest of Middle East & Africa polyclonal antibodies market size, by application, 2018 - 2022 (USD Million)
  • TABLE 300 Rest of Middle East & Africa polyclonal antibodies market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 301 Rest of Middle East & Africa polyclonal antibodies market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 302 Rest of Middle East & Africa polyclonal antibodies market size, by source, 2018 - 2022 (USD Million)
  • TABLE 303 Rest of Middle East & Africa polyclonal antibodies market size, by source, 2023 - 2032 (USD Million)
  • TABLE 304 Rest of Middle East & Africa polyclonal antibodies market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 305 Rest of Middle East & Africa polyclonal antibodies market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Polyclonal antibodies market industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by product
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by source
  • FIG 11 Growth potential analysis, by end-user
  • FIG 12 Porter's analysis
  • FIG 13 PESTEL analysis
  • FIG 14 Company matrix analysis, 2022
  • FIG 15 Competitive analysis of major market players, 2022
  • FIG 16 Competitive positioning matrix, 2022
  • FIG 17 Strategic dashboard, 2022